Get started
alpha62539

LNTH right direction as business and the price could improve

Long
Lantheus Holdings, Inc. (NASDAQ:LNTH)  
alpha62539  
NASDAQ:LNTH   Lantheus Holdings, Inc.
Trend Analysis Chart Patterns Fundamental Analysis LNTH revenueup support tradeidea longidea bullishidea
3
2
trendanalysis chartpattern fundamental lnth revenueup support tradeidea longidea bullishidea
LNTH recently purchased cancer drugs license which are in the Phase 1 with FDA, that look promising. The company raised some cash through senior convertible notes. Quarterly revenue grew 134% YoY to $239.3mm, driven by strengths across the portfolio.
Management raised Q4 and FY22 guidance to the upside from the top-bottom lines. Last ER looks like: Lantheus Non-GAAP EPS of $0.99 beats by $0.16, revenue of $239.29M beats by $11.41M.
The stock price retraced to its long term support zone and could start move up towards 80$ area.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.